CD20 is not a poor prognostic factor for childhood B-lineage acute lymphoblastic leukemia with high white blood cell count

Lu-Yang ZHANG; Xiao-Juan CHEN; Shu-Chun WANG; Ye GUO; Wen-Yu YANG; Yu-Mei CHEN; Li ZHANG; Yao ZOU; Xiao-Fan ZHU.
Chinese Journal of Contemporary Pediatrics ; (12): 728-733, 2020.
Artículo en Zh | WPRIM | ID: wpr-828676

Documentos relacionados

  1. [CD20 is not a poor prognostic factor for childhood B-lineage acute lymphoblastic leukemia with high white blood cell count].
  2. CD371-positive pediatric B-cell acute lymphoblastic leukemia: propensity to lineage switch and slow early response to treatment.
  3. A human genome editing-based MLL::AF4 ALL model recapitulates key cellular and molecular leukemogenic features.
  4. Relevance of CD20 antigen expression among paediatric patients with B-lineage acute lymphoblastic leukaemia.
  5. Biochemical and Hematologic Profiles in B-Cell Acute Lymphoblastic Leukemia Children.
  6. [Expression of CD20 in B-cell precursor acute lymphoblastic leukemia and its correlation with clinical outcomes].
  7. Clinical, biological, and outcome features of P2RY8-CRLF2 and CRLF2 over-expression in pediatric B-cell precursor acute lymphoblastic leukemia according to the CCLG-ALL 2008 and 2018 protocol.
  8. Germ line genetic NBN variation and predisposition to B-cell acute lymphoblastic leukemia in children.
  9. Measurable residual disease detection by high-throughput sequencing improves risk stratification for pediatric B-ALL.
  10. Cuplike nuclei in B-cell acute lymphoblastic leukemia with DUX4 rearrangement.